Biomagnetics Diagnostics, Hubei Tianyuan Chemical Sign Merger Agreement

Biomagnetics Diagnostics Corp. (PINK SHEETS:BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, recently announced its formal signing of a merger agreement between Biomagnetics Diagnostics Crop. and Hubei Tianyuan Chemical Co., Ltd.

Biomagnetics has signed a formal merger agreement with Hubei Tianyuan Chemical Co., Ltd., with a closing date set for September 30th, 2010. This merger brings 42 million dollars in assets, including land to expand, when necessary, to meet future production levels to fill anticipated market demands.

Clayton Hardman, President of Biomagnetics, states: “This merger is the king pin to our marketing and manufacturing of Bio-Fuels. With their existing foundations and similar vision we have dramatically reduced our lead time to market and revenue streams.”

Clayton continues, “Doing business overseas has always been a stressful experience, but the experienced management staff Chairman Yu has assembled will provide strength and stability in moving forward.”

Our team is currently traveling to Fuzhou, China to meet with potential customers for the Hubei Chemical’s existing product line and our newly added Bio-Fuels.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.